Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin
Rhea-AI Summary
Allergan Aesthetics (NYSE: ABBV) opened the new Allergan Medical Institute (AMI) Austin on April 7, 2026, its third U.S. AMI Training Center in the past year. The state-of-the-art facility offers immersive, hands-on education across facial injectables, body contouring, skincare, and regenerative medicine to advance clinical proficiency for providers.
AMI Austin emphasizes advanced injection techniques, complication management, practice development, and peer collaboration under Medical Director Dr. Saami Khalifian, supporting the company’s broader training network including Orange County and Atlanta centers.
Positive
- None.
Negative
- None.
News Market Reaction – ABBV
In the Apr 7 session, ABBV declined 0.15%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 31 | Promotional campaign | Positive | +2.0% | CoolMonth promotion with discounts and giveaways for CoolSculpting treatments. |
| Mar 31 | Promotion correction | Positive | +2.0% | Corrected details on CoolMonth discounts and Instagram giveaways. |
| Mar 31 | Earnings call notice | Neutral | +2.0% | Announcement of Q1 2026 earnings release and webcast schedule. |
| Mar 30 | Clinical data update | Positive | +1.8% | AAD e-poster data on TrenibotE efficacy, safety, and GLP‑1 patient behavior. |
| Mar 27 | Dermatology evidence | Positive | -0.8% | New clinical and real‑world evidence across immune‑mediated skin diseases. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent Allergan Aesthetics and AbbVie news skew positive, with most items followed by modestly positive price reactions.
Over late March 2026, AbbVie/Allergan Aesthetics issued several updates spanning promotions, clinical data, and corporate events. On March 27, AbbVie highlighted dermatology evidence and long-term outcomes. On March 30, Allergan Aesthetics shared Phase 3 and real‑world TrenibotE and GLP‑1 patient findings. Multiple CoolSculpting promotions were announced on March 31, alongside notice of the upcoming April 29, 2026 Q1 earnings call. These events typically coincided with small positive moves, framing today’s training-center expansion as part of a continued aesthetics growth narrative.
Key Terms
allergan medical institute medical
body contouring medical
regenerative medicine medical
complication management medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
- The Allergan Medical Institute (AMI)
Austin location strengthens the national training network with comprehensive, hands-on education. - The
Orange County and Atlanta AMI centers continue delivering best-in-class, expert-led aesthetics training focused on improving the treatment experience for patients.
Designed as a state-of-the-art, interactive learning environment, AMI Austin provides an immersive experience that inspires and engages healthcare professionals, advances clinical proficiency for all levels of providers, and creates a welcoming environment for professionals to learn from each other.
AMI Austin brings the same high-impact educational model synonymous with AMI Training Centers, blending scientific rigor with practical application. Through a comprehensive curriculum and hands-on instruction, the center equips providers with clinical, consultative, and business skills needed to deliver safe, effective, and patient-centered outcomes.
"The opening of AMI Austin represents another important milestone in our commitment to elevating aesthetics education standards," said Glen Curran, Senior Vice President,
Under the direction of Dr. Saami Khalifian, Double Board-Certified Dermatologist and Medical Director for the AMI Training Centers, the center will offer tailored learning opportunities across experience levels, with a focus on advanced injection techniques, complication management, and practice development. The center provides training across the Allergan Aesthetics portfolio, including facial injectables, body contouring, skincare, and plastic and regenerative medicine. Participants will gain the skills, confidence, and peer connections necessary to accelerate career and practice growth within a collaborative professional community.
As Allergan Aesthetics continues to expand its on-site training footprint, insights from AMI Austin will help inform future AMI innovation. Learnings from real-world programming and provider feedback will guide the evolution of AMI's forward-looking strategy, ensuring future centers are built for scalability, adaptability, and impact with customers.
The new location joins a growing
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.AllerganAesthetics.com.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
About Allergan Medical Institute (AMI)
Allergan Medical Institute (AMI) is the training arm of Allergan Aesthetics, dedicated to advancing excellence in aesthetics education. AMI provides innovative, high-quality training programs across the Allergan Aesthetics portfolio to empower providers and business owners to elevate patient experiences and outcomes. Learn more at https://us.allerganmedicalinstitute.com.
About AMI Online
AMI Online is a comprehensive, on-demand learning platform offering in-depth education across the Allergan Aesthetics portfolio. Available 24/7, AMI Online supports injectors and practice teams through personalized learning experiences, expert-led content, certification opportunities, and access to upcoming educational events.
Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.
Contacts:
Allergan Aesthetics Media:
Ember Garrett
Ember.Garrett@allergan.com
+1 (949) 413-6091
AbbVie Investors:
Liz Shea
Liz.Shea@abbvie.com
+1 (847) 935-2211
View original content to download multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-third-state-of-the-art-ami-center-opens-in-austin-302735154.html
SOURCE Allergan Aesthetics, an AbbVie company